Literature DB >> 31053572

Structural basis of the leukocyte integrin Mac-1 I-domain interactions with the platelet glycoprotein Ib.

Juliet Morgan1, Muhammad Saleem2, Ruiqi Ng2, Caroline Armstrong1, Szu S Wong2, Simon G Caulton2, Alice Fickling1, Huw E L Williams1, Adam D Munday3, José A López3, Mark S Searle1, Jonas Emsley2.   

Abstract

Cell-surface receptor interactions between leukocyte integrin macrophage-1 antigen (Mac-1, also known as CR3, αMβ2, CD11b/CD18) and platelet glycoprotein Ibα (GPIbα) are critical to vascular inflammation. To define the key residues at the binding interface, we used nuclear magnetic resonance (NMR) to assign the spectra of the mouse Mac-1 I-domain and mapped the residues contacting the mouse GPIbα N-terminal domain (GPIbαN) to the locality of the integrin metal ion-dependant adhesion site (MIDAS) surface. We next determined the crystal structures of the mouse GPIbαN and Mac-1 I-domain to 2 Å and 2.5 Å resolution, respectively. The mouse Mac-1 I-domain crystal structure reveals an active conformation that is stabilized by a crystal contact from the α7-helix with a glutamate side chain completing the octahedral coordination sphere of the MIDAS Mg2+ ion. The amino acid sequence of the α7-helix and disposition of the glutamic acid matches the C-terminal capping region α-helix of GPIbα effectively acting as a ligand mimetic. Using these crystal structures in combination with NMR measurements and docking analysis, we developed a model whereby an acidic residue from the GPIbα leucine-rich repeat (LRR) capping α-helix coordinates directly to the Mac-1 MIDAS Mg2+ ion. The Mac-1:GPIbαN complex involves additional interactions consolidated by an elongated pocket flanking the GPIbαN LRR capping α-helix. The GPIbαN α-helix has an HxxxE motif, which is equivalent by homology to RxxxD from the human GPIbαN. Subsequent mutagenesis of residues at this interface, coupled with surface plasmon resonance studies, confirmed the importance of GPIbαN residues H218, E222, and the Mac-1 MIDAS residue T209 to formation of the complex.
© 2019 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31053572      PMCID: PMC6517656          DOI: 10.1182/bloodadvances.2018027011

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  36 in total

1.  Structural basis of collagen recognition by integrin alpha2beta1.

Authors:  J Emsley; C G Knight; R W Farndale; M J Barnes; R C Liddington
Journal:  Cell       Date:  2000-03-31       Impact factor: 41.582

2.  An isoleucine-based allosteric switch controls affinity and shape shifting in integrin CD11b A-domain.

Authors:  J P Xiong; R Li; M Essafi; T Stehle; M A Arnaout
Journal:  J Biol Chem       Date:  2000-12-08       Impact factor: 5.157

3.  Identification and characterization of the integrin alpha2beta1 binding motif in chondroadherin mediating cell attachment.

Authors:  Lisbet Haglund; Viveka Tillgren; Laura Addis; Christina Wenglén; Anneliese Recklies; Dick Heinegård
Journal:  J Biol Chem       Date:  2010-12-02       Impact factor: 5.157

4.  Crystal structure of the A domain from the alpha subunit of integrin CR3 (CD11b/CD18).

Authors:  J O Lee; P Rieu; M A Arnaout; R Liddington
Journal:  Cell       Date:  1995-02-24       Impact factor: 41.582

Review 5.  Thrombosis as an intravascular effector of innate immunity.

Authors:  Bernd Engelmann; Steffen Massberg
Journal:  Nat Rev Immunol       Date:  2012-12-07       Impact factor: 53.106

6.  Modulation of alpha-thrombin function by distinct interactions with platelet glycoprotein Ibalpha.

Authors:  Reha Celikel; Richard A McClintock; James R Roberts; G Loredana Mendolicchio; Jerry Ware; Kottayil I Varughese; Zaverio M Ruggeri
Journal:  Science       Date:  2003-07-11       Impact factor: 47.728

7.  Structural Basis for Simvastatin Competitive Antagonism of Complement Receptor 3.

Authors:  Maria Risager Jensen; Goran Bajic; Xianwei Zhang; Anne Kjær Laustsen; Heidi Koldsø; Katrine Kirkeby Skeby; Birgit Schiøtt; Gregers R Andersen; Thomas Vorup-Jensen
Journal:  J Biol Chem       Date:  2016-06-23       Impact factor: 5.157

8.  Crystal structure of the platelet glycoprotein Ib(alpha) N-terminal domain reveals an unmasking mechanism for receptor activation.

Authors:  Sarah Uff; Jeannine M Clemetson; Tim Harrison; Kenneth J Clemetson; Jonas Emsley
Journal:  J Biol Chem       Date:  2002-06-26       Impact factor: 5.157

9.  The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b/CD18) for four distinct adhesion ligands.

Authors:  M S Diamond; J Garcia-Aguilar; J K Bickford; A L Corbi; T A Springer
Journal:  J Cell Biol       Date:  1993-02       Impact factor: 10.539

10.  Targeting platelet-leukocyte interactions: identification of the integrin Mac-1 binding site for the platelet counter receptor glycoprotein Ibalpha.

Authors:  Raila Ehlers; Valentin Ustinov; Zhiping Chen; Xiaobin Zhang; Ravi Rao; F William Luscinskas; Jose Lopez; Edward Plow; Daniel I Simon
Journal:  J Exp Med       Date:  2003-10-06       Impact factor: 14.307

View more
  4 in total

Review 1.  CD11b agonists offer a novel approach for treating lupus nephritis.

Authors:  Veronica Villanueva; Xiaobo Li; Viviana Jimenez; Hafeez M Faridi; Vineet Gupta
Journal:  Transl Res       Date:  2022-03-12       Impact factor: 10.171

2.  Molecular basis for Ras suppressor-1 binding to PINCH-1 in focal adhesion assembly.

Authors:  Koichi Fukuda; Fan Lu; Jun Qin
Journal:  J Biol Chem       Date:  2021-04-21       Impact factor: 5.486

3.  MD Simulations on a Well-Built Docking Model Reveal Fine Mechanical Stability and Force-Dependent Dissociation of Mac-1/GPIbα Complex.

Authors:  Xiaoyan Jiang; Xiaoxi Sun; Jiangguo Lin; Yingchen Ling; Ying Fang; Jianhua Wu
Journal:  Front Mol Biosci       Date:  2021-04-22

4.  Type IV Pili of Streptococcus sanguinis Contribute to Pathogenesis in Experimental Infective Endocarditis.

Authors:  Anthony M Martini; Bridget S Moricz; Laurel J Woods; Bradley D Jones
Journal:  Microbiol Spectr       Date:  2021-11-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.